Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution
Authors
Keywords
Angiosarcoma, Checkpoint inhibitors, CTLA-4 antibody, Fusions, Tumor mutation burden
Journal
Journal for ImmunoTherapy of Cancer
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-08
DOI
10.1186/s40425-019-0689-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial
- (2019) Breelyn A Wilky et al. LANCET ONCOLOGY
- Current and Future Directions for Angiosarcoma Therapy
- (2018) Vaia Florou et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials
- (2018) Sandra P D'Angelo et al. LANCET ONCOLOGY
- Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody
- (2018) Randi B. Gombos et al. PLoS One
- Mutational landscape of radiation-associated angiosarcoma of the breast
- (2018) Bryan J. Thibodeau et al. Oncotarget
- Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
- (2018) Qingsong Gao et al. Cell Reports
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- (2017) Samra Turajlic et al. LANCET ONCOLOGY
- Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
- (2017) Martin Lauss et al. Nature Communications
- Angiosarcoma treated successfully with anti-PD-1 therapy - a case report
- (2017) Simran Sindhu et al. Journal for ImmunoTherapy of Cancer
- Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade
- (2016) Tavi Nathanson et al. Cancer Immunology Research
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAFFA: High sensitivity transcriptome-focused fusion gene detection
- (2015) Nadia M Davidson et al. Genome Medicine
- CTLA-4 Is Expressed by Activated Mouse NK Cells and Inhibits NK Cell IFN- Production in Response to Mature Dendritic Cells
- (2014) A. Stojanovic et al. JOURNAL OF IMMUNOLOGY
- Integrated Analysis of Mutation Data from Various Sources Identifies Key Genes and Signaling Pathways in Hepatocellular Carcinoma
- (2014) Yuannv Zhang et al. PLoS One
- SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data
- (2013) Wenlong Jia et al. GENOME BIOLOGY
- Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
- (2012) J. G. Lohr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Angiosarcoma
- (2010) Guy Lahat et al. ANNALS OF SURGERY
- Effector/Memory but Not Naive Regulatory T Cells Are Responsible for the Loss of Concomitant Tumor Immunity
- (2009) Yung-Chang Lin et al. JOURNAL OF IMMUNOLOGY
- Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
- (2008) Nicolas Penel et al. JOURNAL OF CLINICAL ONCOLOGY
- CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
- (2008) L. G. Almeida et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now